Last reviewed: June 23, 2026
Last updated: June 23, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, produced an average 15% body weight reduction in initial FDA trials and up to 22% in extended studies. Weight loss timelines vary significantly between individuals based on starting weight, metabolism, and treatment adherence. Understanding realistic expectations helps you set achievable goals and stay committed to your health journey.
Average Weight Loss on Semaglutide Injections
The STEP clinical trial program tracked semaglutide's effects across diverse populations. Participants receiving the highest maintenance dose (2.4 mg weekly) lost an average of 15.3% of their starting body weight over 68 weeks. Extended follow-up data showed sustained losses of 17–22% when users continued treatment consistently. These results represent approximately 15–20 pounds lost per month during the first 3–4 months, with weight loss continuing at a slower pace thereafter.
Individual results depend on multiple factors including baseline weight, age, diet quality, and exercise patterns. Someone starting at 250 pounds might lose 35–55 pounds over one year, while a person starting at 180 pounds could expect 27–40 pounds of reduction. Plateaus are normal and typically occur after 4–6 months of consistent use, signaling metabolic adaptation rather than treatment failure.
How Semaglutide Works to Reduce Body Weight
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and blood sugar. It activates receptors in the brain's satiety centers, decreasing hunger signals and increasing feelings of fullness with smaller meal portions. The medication also slows stomach emptying, keeping you satisfied longer after eating. This combination reduces overall calorie intake without requiring extreme dietary restriction or willpower alone.
The drug works on multiple appetite-related pathways simultaneously. Reduced cravings for high-calorie foods, decreased snacking urges, and natural portion control emerge within the first 2–3 weeks of treatment. Users consistently report eating 30–40% fewer calories than baseline without feeling deprived, which supports sustainable long-term weight loss rather than temporary crash-diet results.
Timeline for Seeing Weight Loss Results
Most users notice appetite suppression within 3–5 days of their first injection, though measurable weight loss typically begins in week 2–3. The first month often yields 4–8 pounds of weight loss as the body's calorie deficit deepens. Months 2–4 show accelerated loss, with many people losing 8–12 pounds monthly. After month 4, the pace typically slows to 2–4 pounds per month as the body adjusts to the new weight set point.
Dose escalation affects timelines significantly. PlexusDx personalizes dosing based on individual tolerance and metabolic response. Some patients achieve full benefits at lower doses, while others require the standard 2.4 mg maintenance dose for optimal results. Genetic factors affecting peptide sensitivity, measured through the PlexusDx Precision Peptide Genetic Test, can predict which patients respond fastest to treatment initiation.
Factors That Influence Your Personal Weight Loss Results
Baseline body mass index (BMI) is a strong predictor of total weight loss percentage. Individuals with higher starting weights often experience greater absolute poundage loss, while lower BMI patients may see smaller but still clinically meaningful reductions. Age plays a secondary role—metabolism naturally slows with age, so older adults might lose slightly less weight monthly but maintain losses effectively. Previous weight loss attempts and insulin resistance history also influence responsiveness.
Lifestyle factors amplify semaglutide's effects dramatically. Users who combine the medication with regular physical activity (150 minutes weekly) and whole-food nutrition lose 5–10% more weight than those relying on medication alone. Sleep quality, stress management, and alcohol consumption impact both metabolism and treatment adherence. PlexusDx genetic testing identifies individual peptide-pathway variations that predict which patients will benefit most from early intervention or dose adjustments, enabling precision-guided therapy from day one.
Realistic Expectations: What Wegovy Cannot Deliver
Semaglutide is a powerful tool, not a magic solution. Weight loss plateaus after 12–18 months of treatment as the body reaches a new equilibrium. Continuing the medication maintains that lower weight but doesn't produce indefinite additional loss. Some patients plateau at 20–25 pounds of loss rather than reaching their ideal weight, reflecting individual metabolic set points.
Discontinuing treatment without lifestyle changes typically results in gradual weight regain over 6–12 months as appetite hormones normalize. Successful long-term outcomes combine semaglutide therapy with sustained dietary awareness and movement habits. Users who view the medication as a 12–24 month reset tool rather than permanent appetite suppression report greater satisfaction and better maintenance of results after treatment completion.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight will I lose in my first month on semaglutide?
Most PlexusDx patients lose 4–8 pounds in month one as appetite suppression deepens and calorie intake naturally decreases. Exact results depend on starting weight and baseline metabolism. Measurable changes typically appear by week 2–3 of treatment.
Is 15–22% weight loss realistic for everyone?
Clinical trial averages of 15–22% body weight loss apply to consistent users over 68 weeks. Individual results vary widely based on genetics, baseline BMI, and lifestyle factors. Some patients lose 25%+ while others achieve 10–12% despite proper adherence—both represent significant health improvements.
Can PlexusDx help me achieve faster weight loss than Wegovy?
PlexusDx compounded semaglutide injections deliver identical active ingredients to brand-name Wegovy at lower cost starting at $149/month. Personalized dosing based on your individual response, combined with optional Precision Peptide Genetic Testing, helps optimize your timeline. Your dose may need to go up. Your price won't.
What happens to weight loss if I take a break from semaglutide?
Even short breaks (2–4 weeks) can restart appetite signaling, potentially undoing months of progress. Extended discontinuation typically leads to gradual weight regain over 6–12 months. Consistent adherence to your prescribed injection schedule is critical for maintaining results.
How does genetic testing improve my weight loss outcomes?
PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R pathways that predict treatment response. Testing reveals which patients achieve faster results, respond to lower doses, or benefit from combination therapy like GLP-Squared. This personalization means optimized treatment from month one rather than guessing.
Will I regain weight after stopping semaglutide?
Yes—without medication, appetite hormones gradually normalize and weight regain typically occurs over 6–12 months if lifestyle habits remain unchanged. Many patients maintain 50–70% of their loss through continued healthy eating patterns. Long-term success requires viewing semaglutide as a reset tool paired with sustainable behavior change.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Is Ozempic Not Working for Weight Loss?
Navigating Your Journey: What Happens If You Skip a Dose of Ozempic?